2020
DOI: 10.1016/j.ejmech.2020.112435
|View full text |Cite
|
Sign up to set email alerts
|

Discovery of phenylselenoether-hydantoin hybrids as ABCB1 efflux pump modulating agents with cytotoxic and antiproliferative actions in resistant T-lymphoma

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
29
1

Year Published

2021
2021
2025
2025

Publication Types

Select...
6
1

Relationship

3
4

Authors

Journals

citations
Cited by 35 publications
(31 citation statements)
references
References 43 publications
1
29
1
Order By: Relevance
“…The opposite results, however, were observed for the fluorophenyl derivatives. In contrast to the previous studies concerning hydantoin derivatives, [27] the resultant lipophilicity of compounds did not affect the ABCB1 modulating potency in this series ( 7 – 23 ). As the clearest example, the most lipophilic compound 21 did not demonstrate ABCB1‐modulating action, while the most active modulator 22 showed in 1‐unit lower lipophilicity than that of 21 (2.30 vs 3.35, Figure 5).…”
Section: Resultscontrasting
confidence: 99%
See 2 more Smart Citations
“…The opposite results, however, were observed for the fluorophenyl derivatives. In contrast to the previous studies concerning hydantoin derivatives, [27] the resultant lipophilicity of compounds did not affect the ABCB1 modulating potency in this series ( 7 – 23 ). As the clearest example, the most lipophilic compound 21 did not demonstrate ABCB1‐modulating action, while the most active modulator 22 showed in 1‐unit lower lipophilicity than that of 21 (2.30 vs 3.35, Figure 5).…”
Section: Resultscontrasting
confidence: 99%
“…In this context, the mechanism of ABCB1 modulation observed in the rhodamine 123 accumulation assay for compounds 12 , 20 , and 22 (Table 4) was not associated with the pump inactivation via ATPase inhibition. These results are in compilations with previous ones obtained for imidazolones and hydantoins [24,27] . It suggests a competition with the dye‐substrate towards ABCB1 binding site as the most probable mechanism of the pump modulating action for compounds 12 , 20 and 22 .…”
Section: Resultssupporting
confidence: 85%
See 1 more Smart Citation
“…For the compound RSe-2, Se-alkylation of 1-bromo-4-chlorobutane was performed under a nitrogen atmosphere and in absolute ethanol at RT. The crude product was then reacted with methyl piperazine in the presence of anhydrous K 2 CO 3 and acetone at 50 °C ( Scheme 2 ) [ 19 ]. The structure and purity of the final compounds were confirmed via spectroscopic and chromatographic methods.…”
Section: Methodsmentioning
confidence: 99%
“…Thus, the search for new ABCB1 modulators is a still an ongoing challenge of the pharmaceutical industry. In this context, our research team has explored a new class of chemical compounds, including derivatives of various (un)substituted 5-arylhydantoins and 5-arylidenehydantoins (Spengler et al, 2010(Spengler et al, , 2011Ali et al, 2020), 5,5-dimethylhydantoins (Martins et al, 2012), arylidene-imidazolones (Handzlik et al, 2012;Kaczor et al, 2020) and spirofluorene-imidazolidinediones (Ż esławska et al, 2016, 2019, 2021). Among the 3-methyl-5spirofluorenehydantoin derivatives with arylpiperazine-alkyl groups, substitution at position 1 produced the most potent ABCB1 modulators, with the ability to inhibit the efflux pump with 5-25 times more potentcy than verapamil, a known firstgeneration ABCB1-modulator (Ż esławska et al, 2019, 2021).…”
Section: Introductionmentioning
confidence: 99%